A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-880 in Subjects Who Have Type 1 Diabetes Mellitus With Impaired Hypoglycemic Awareness and Severe Hypoglycemia

Principal Investigator

Prof Paul R V Johnson

Contact us

Email: diabetes.research1@ouh.nhs.uk

IRAS number

1006463